Patent · US Active

Compounds and compositions as TPO mimetics

US7816542B2 · kind B2 · utility

0Cited by
8References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2006
Grant dateOct 19, 2010
Priority date
Expiry dateNov 24, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D235/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TPO activity, particularly diseases or disorders that involve thrombocytopenia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.